Doxycycline
Product Images NDC 61919-474

14 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Doxycycline (NDC 61919-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label)

Image Description (Label)
Doxycycline 100 mg label for 20 tablets by Direct Rx, generic for Adoxa. The label shows that each tablet contains doxycycline monohydrate equivalent to 100 mg doxycycline USP. It includes lot number Prod# 474-20 and a discard date of 09/17. Packaging also provides storage information and warnings to keep out of reach of children.*
FDA Label Image

Image Description (Molecule)

Image Description (Molecule)
Chemical structure of doxycycline, showing its molecular formula C22H24N2O8·H2O and molecular weight 462.45. The structure depicts multiple hydroxyl, carbonyl, and amino functional groups characteristic of doxycycline's tetracycline antibiotic framework.*
FDA Label Image

Image Description (Table1 1)

Image Description (Table1 1)
A data table presenting observed pharmacokinetic values including concentrations in mcg/mL and time in hours, with standard deviations shown. The table appears to summarize measured values related to doxycycline, reflecting dosage or concentration variation over time.*
FDA Label Image

Image Description (Table1)

Image Description (Table1)
A data table presenting values for time in hours (0.5, 1.0, 1.5, 2.0, 3.0) and corresponding concentrations in micrograms per milliliter (1.02, 2.26, 2.67, 3.01, 3.16). Below the table are labels for Maximum Concentration, Time of Maximum Concentration, Elimination Rate Constant, and Half-Life, without values shown.*
FDA Label Image

Image Description (Table2 1)

Image Description (Table2 1)
A data table presenting antibiotic susceptibility values for various bacteria, including Norcardiae and other aerobic Actinomyces species, Streptococcus pneumonia, Vibrio cholera, Yersinia pestis, and Ureaplasma urealyticum. The table compares the susceptibility ranges for Doxycycline and Tetracycline antibiotics against these bacteria.*
FDA Label Image

Image Description (Table2 2)

Image Description (Table2 2)
Data table listing agar dilution susceptibility breakpoints for Doxycycline in micrograms per milliliter (mcg/mL) categorized by S (Susceptible), I (Intermediate), and R (Resistant). The table presents breakpoint values such as ≤4 for Susceptible, 8 for Intermediate, and ≥16 for Resistant, alongside additional breakpoint values for related results.*
FDA Label Image

Image Description (Table2 3)

Image Description (Table2 3)
A data table presenting categorical variables distributed across rows and columns with possible numerical or symbolic entries. The table appears to organize data into multiple sections, some cells highlighted in light blue for emphasis or grouping. No specific titles or headers are visible for the rows or columns.*
FDA Label Image

Image Description (Table2)

Image Description (Table2)
A data table titled 'Susceptibility Test Interpretive Criteria for Doxycycline and Tetracycline' showing minimal inhibitory concentration (mcg per mL) and zone diameter (mm) criteria for various bacteria, including Acinetobacter spp., Bacillus anthracis, Brucella species, Enterobacteriaceae, Francisella tularensis, Haemophilus influenza, Mycoplasma pneumoniae, and Neisseria gonorrhoeae, comparing doxycycline and tetracycline susceptibility values.*
FDA Label Image

Image Description (Table3)

Image Description (Table3)
A data table listing different packaging options for Doxycycline Tablets 50 mg by Direct Rx. It includes blister packages of 10 tablets, cartons of 30 tablets (3 x 10 unit dose tablets), bottles of 100, and bottles of 500, each with corresponding NDC codes.*
FDA Label Image

Image Description (Table4)

Image Description (Table4)
Data table listing available packaging and corresponding NDC codes for Doxycycline Tablets 75 mg. Packaging options include blister packages of 10, cartons of 30 (3 x 10 unit dose tablets), and bottles of 100 or 500 tablets, with unique NDC codes for each package size.*
FDA Label Image

Image Description (Table5)

Image Description (Table5)
A data table listing different packaging configurations of Doxycycline Tablets 100 mg, including blister packages of 10 tablets, cartons of 30 tablets (3 x 10 unit dose tablets), bottles of 50 tablets, and bottles of 500 tablets, each with corresponding NDC codes.*
FDA Label Image

Image Description (Table6)

Image Description (Table6)
A data table listing packaging types and corresponding NDC numbers for Doxycycline Tablets 150 mg. Packaging options include a blister package of 10 tablets, a carton of 30 tablets (3 x 10 unit dose), bottles of 30 tablets, and bottles of 500 tablets, each with unique NDC codes.*
FDA Label Image

Image Description (Table7 1)

Image Description (Table7 1)
A data table displaying microbial strains including Bacteroides fragilis, Bacteroides thetaiotaomicron, Mycoplasma pneumoniae, and Ureaplasma urealyticum with associated Tetracycline sensitivity ranges expressed numerically for each strain.*
FDA Label Image

Image Description (Table7)

Image Description (Table7)
Table titled 'Acceptable Quality Control Ranges for Susceptibility Testing for Doxycycline and Tetracycline' listing QC strains with corresponding minimal inhibitory concentration, zone diameter, and agar dilution values for doxycycline and tetracycline susceptibility testing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.